Professor David Werring is a full professor at UCL Queen Square Institute of Neurology and is the Chair of the Association of British Neurologists Stroke Advisory Group
| David did a BSc. in Neurosciences (1989) and qualified in medicine from Guy’s Hospital Medical School in 1992. He became a Member of the Royal Colleges of Physicians of the United Kingdom (MRCP) in 1995 and finished his PhD in clinical neurology in applied structural and functional brain imaging at the UCL Queen Square Institute of Neurology in 2000. After completing clinical training in neurology and stroke medicine in 2004, he was appointed consultant neurologist at the National Hospital for Neurology and Neurosurgery, University College Hospital and Watford General Hospital in 2005. David was made Reader in clinical neurology and honorary consultant neurologist in 2008, became a fellow of the Royal College of Physicians (FRCP) in 2012 and was appointed as a full professor at UCL Queen Square Institute of Neurology in 2015. In 2017, he became head of the research department of Brain Repair & Rehabilitation at the UCL Queen Square Institute of Neurology David delivers acute and outpatient stroke care and leads a research program focussed on improving understanding, diagnosis, and treatment of cerebral small vessel disease (the commonest known brain disorder, and a major cause of stroke and dementia). He is Chair of the Association of British Neurologists Stroke Advisory Group, Stroke Specialty Lead for the NIHR North Thames Clinical Research Network, President-Elect of the British and Irish Association of Stroke Physicians, and editorial board member of the European Journal of Neurology, European Stroke Journal, International Journal of Stroke and Practical Neurology. David Chaired the UK Stroke Forum, the largest multidisciplinary conference for stroke professional in the UK, from 2020-2022. At Clare Hall David will be hosted by the University Department of Clinical Neurosciences where he plans to develop specialist clinical knowledge and collaborations, write, and develop ideas for new treatments for cerebral small vessel disease. |
Select publications
| Banerjee G, Samra K, Adams ME, Jaunmuktane Z, Parry-Jones AR, Grieve J, Toma AK, Farmer SF, Sylvester R, Houlden H, Rudge P, Mead S, Brandner S, Schott JM, Collinge J, Werring DJ. Iatrogenic cerebral amyloid angiopathy: an emerging clinical phenomenon. J Neurol Neurosurg Psychiatry. 2022 May 16:jnnp-2022-328792. doi: 10.1136/jnnp-2022-328792. Epub ahead of print. PMID: 35577510. Best, JG; Ambler, G; Wilson, D; et, al; Werring, DJ (2021). “Microbleeds International Collaborative Network. Development of imaging-based risk scores for prediction of intracranial haemorrhage and ischaemic stroke in patients taking antithrombotic therapy after ischaemic stroke or transient ischaemic attack: a pooled analysis of individual patient data from cohort studies”. The Lancet Neurology. 20 (4): 294–303. doi:10.1016/S1474-4422(21)00024-7. PMID 33743239. S2CID 232265303. Beyrouti R, Adams ME, Benjamin L, Cohen H, Farmer SF, Goh YY, Humphries F, Jäger HR, Losseff NA, Perry RJ, Shah S, Simister RJ, Turner D, Chandratheva A, Werring DJ (2020). Characteristics of ischaemic stroke associated with COVID-19. J Neurol Neurosurg Psychiatry. 91(8): 889-891. doi: 10.1136/jnnp-2020-323586. Epub 2020 Apr 30. PMID: 32354768; PMCID: PMC7231545. Seiffge, DJ; Werring, DJ; Paciaroni, M; Dawson, J; Warach, S; Milling, TJ; Engelter, ST; Fischer, U; Norrving, B (2019). “Timing of anticoagulation after recent ischaemic stroke in patients with atrial fibrillation”. The Lancet Neurology. 18 (1): 117–126. doi:10.1016/S1474-4422(18)30356-9. PMC 6524642. PMID 30415934. Wilson, D; Ambler, G; Lee, K-J; et, al; Werring, DJ (2019). “Cerebral microbleeds and stroke risk after ischaemic stroke or transient ischaemic attack: a pooled analysis of individual patient data from cohort studies”. The Lancet Neurology. 18 (7): 653–665. doi:10.1016/S1474-4422(19)30197-8. PMC 6562236. PMID 31130428. Wilson, D; Ambler, G; Shakeshaft, C; et, al; Werring, DJ (2018). “CROMIS-2 collaborators. Cerebral microbleeds and intracranial haemorrhage risk in patients anticoagulated for atrial fibrillation after acute ischaemic stroke or transient ischaemic attack (CROMIS-2): multicentre observational cohort study”. The Lancet Neurology. 17 (6): 539–547. doi:10.1016/S1474-4422(18)30145-5. PMC 5956310. PMID 29778365. Banerjee, G; Carare, R; Cordonnier, C; Greenberg, SM; Schneider, JA; Smith, EE; Buchem, MV; Grond, JV; Verbeek, MM; Werring, DJ (2017). “The increasing impact of cerebral amyloid angiopathy: essential new insights for clinical practice”. Journal of Neurology, Neurosurgery, and Psychiatry. 88 (11): 982–994. doi:10.1136/jnnp-2016-314697. PMC 5740546. PMID 28844070. |
Select Awards
President-Elect of the British and Irish Association of Stroke Physicians Stroke Specialty Lead for the NIHR North Thames Clinical Research Network Chair of the Association of British Neurologists Stroke Advisory Group Editorial board member of the European Journal of Neurology, European Stroke Journal, International Journal of Stroke and Practical Neurology |
